Psychiatry Research, Год журнала: 2025, Номер unknown, С. 116499 - 116499
Опубликована: Апрель 1, 2025
Язык: Английский
Psychiatry Research, Год журнала: 2025, Номер unknown, С. 116499 - 116499
Опубликована: Апрель 1, 2025
Язык: Английский
Research Square (Research Square), Год журнала: 2025, Номер unknown
Опубликована: Фев. 13, 2025
Язык: Английский
Процитировано
0ACS Medicinal Chemistry Letters, Год журнала: 2025, Номер 16(4), С. 520 - 522
Опубликована: Март 6, 2025
Recent advancements in psychedelic therapeutics, tryptamine derivatives, neuroplastic modulators, and AI-powered machine-learning platforms mark a new frontier precision medicine. These innovations address critical challenges neurological psychiatric disorders, chronic pain management, computational accessibility. By harnessing the principles of receptor modulation, targeted delivery systems, simplified AI integration, these breakthroughs promise transformative solutions for patient care technological development.
Язык: Английский
Процитировано
0ACS Medicinal Chemistry Letters, Год журнала: 2025, Номер 16(4), С. 514 - 516
Опубликована: Март 11, 2025
Emerging innovations across psychedelics, artificial intelligence (AI), and communication technologies are reshaping healthcare beyond. This Patent Highlight showcases advancement in sublingual delivery systems for asymmetric phenylethylamine compounds, AI-assisted positioning, multi-modal data fusion, respectively. These inventions address challenges like drug inefficiencies, mental health treatment gaps, precision communication, integrated diagnostics. Together, they demonstrate the transformative potential of cross-disciplinary technological advancements enhancing precision, accessibility, scalability their respective fields.
Язык: Английский
Процитировано
0Psychiatry Research, Год журнала: 2025, Номер unknown, С. 116499 - 116499
Опубликована: Апрель 1, 2025
Язык: Английский
Процитировано
0